+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter evaluation of the antimicrobial activity of gemifloxacin tested against over 6,000 contemporary gram-positive cocci



Multicenter evaluation of the antimicrobial activity of gemifloxacin tested against over 6,000 contemporary gram-positive cocci



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 283




(PDF emailed within 1 workday: $29.90)

Accession: 035349827

Download citation: RISBibTeXText


Related references

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study. International Journal of Antimicrobial Agents 23(2): 181-196, 2004

Comparative in vitro activity of gemifloxacin, moxifloxacin, trovafloxacin, sparfloxacin, grepafloxacin, ofloxacin, ciprofloxacin and other antimicrobial agents against bloodstream isolates of gram-positive cocci. Journal of Antimicrobial Chemotherapy 44(SUPPL A): 146, July, 1999

Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae. International Journal of Antimicrobial Agents 17(6): 451-455, June, 2001

Antimicrobial activity of the novel glycylcycline, GAR-936, tested against over 1000 recent clinical isolates including multiresistant Gram-positive cocci. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 300, 1999

Antimicrobial activity of gatifloxacin tested against 1676 Gram-positive cocci resistant to ciprofloxacin A multicentre organism sample from North and Latin America. Drugs 58(Suppl 2): 162-163, 1999

Antimicrobial activity of gatifloxacin tested against 1,676 gram-positive cocci resistant to ciprofloxacin A multi-center organism sample from North and South America. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 224, 1998

Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America. Diagnostic Microbiology & Infectious Disease 32(3): 247-252, 1998

Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America. Diagnostic Microbiology and Infectious Disease 32(3): 247-252, 1999

Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci. Antimicrobial Agents & Chemotherapy 44(3): 802-805, March, 2000

A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci. Japanese Journal of Antibiotics 51(12): 764-778, 1999

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada. International Journal of Antimicrobial Agents 35(3): 282-287, 2010

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America Results from the Global SMART Surveillance Study. Abstracts of the General Meeting of the American Society for Microbiology 99: 193, 1999

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study. Brazilian Journal of Infectious Diseases 5(1): 21-31, 2001

Contrasting effects of intrinsic antimicrobial activity of serum and ultrafiltrate on gram-positive cocci vs gram-negative bacilli. Abstracts of the General Meeting of the American Society for Microbiology 94(0): 547, 1994